3 Stocks Driving Biotech ETF SBIO's Appeal
Not only has the fund performed well, but it has also seen some exciting data, according to YCharts. The fund's price has risen above both its 50 and 200-day simple moving averages (SMAs), historically an indicator of healthy momentum and a buy signal. In the shifting landscape of ETFs, many funds claim to offer exposure to innovation. Technology plays a key role as a growth industry and a driver for performance across the economy overall, as well. With potentially multiple rate cuts on the horizon, then, i ...